The Relationship between Plasma Erythropoietin Levels and Symptoms of Attention Deficit Hyperactivity Disorder

다국어 초록 (Multilingual Abstract)

Objective: There are animal models associating dopamine dysfunction with behavioral impairments that model attention deficit hyperactivity disorder (ADHD). Erythropoietin (EPO) has trophic effects on dopaminergic neurons. The aim of this study was to examine the EPO plasma levels and determine whether there was any correlation between plasma EPO levels and clinical characteristics of ADHD.
Methods: Plasma EPO levels were measured in 78 drug-naïve children with ADHD and in 81 healthy children. The severity of ADHD symptoms was determined by scores on the Korean ADHD Rating Scale (K-ARS) in ADHD children and healthy controls.
Results: The difference between median plasma EPO levels in ADHD children and in healthy controls was not statistically significant. Adjusting for age and sex, a linear regression analysis showed that inattention score was significantly higher in the second highest tertile of plasma EPO compared to those in the lowest tertile. Hyperactivity-impulsivity score was significantly higher in the highest tertile of plasma EPO compared to those in the lowest tertile. Moreover, total K-ARS scores were significantly higher in the second highest tertile of plasma EPO compared to those in the lowest tertile.
Conclusion: These findings suggest that plasma EPO levels were related to some ADHD symptoms, which could be used in the monitoring of the disorder.

참고문헌 (Reference)

1 소유경, "한국어판 부모, 교사 ADHD 평가 척도의 신뢰도와 타당도 연구" 대한신경정신의학회 41 (41): 283-289, 2002

2 Polanczyk G, "The worldwide prevalence of ADHD : a systematic review and metaregression analysis" 164 : 942-948, 2007

3 김영신, "The Reliability and Validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean Version (K-SADS-PL-K)" 연세대학교의과대학 45 (45): 81-89, 2004

4 Lindström K, "Teenage outcome after being born at term with moderate neonatal encephalopathy" 35 : 268-274, 2006

5 Casals-Pascual C, "Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo" 108 : 2569-2577, 2006

6 Yamamoto M, "Stimulating effect of erythropoietin on the release of dopamine and acetylcholine from the rat brain slice" 292 : 131-133, 2000

7 Maxwell PH, "Sites of erythropoietin production" 51 : 393-401, 1997

8 Kelly AM, "Recent advances in structural and functional brain imaging studies of attentiondeficit/hyperactivity disorder" 9 : 401-407, 2007

9 Russell VA, "Neurobiology of animal models of attention-deficit hyperactivity disorder" 161 : 185-198, 2007

10 Anderson P, "Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s" 289 : 3264-3272, 2003

11 Digicaylioglu M, "Localization of specific erythropoietin binding sites in defined areas of the mouse brain" 92 : 3717-3720, 1995

12 Koury ST, "Localization of cells producing erythropoietin in murine liver by in situ hybridization" 77 : 2497-2503, 1991

13 Park KS, "Korean educational development institute-Wechsler intelligence scale for children (KEDI-WISC)" Korean Educational Development Institute 2002

14 Shim SH, "Increased levels of plasma brain-derived neurotrophic factor(BDNF)in children with attention deficit-hyperactivity disorder(ADHD)" 32 : 1824-1828, 2008

15 Kemal Utku Yazici, "Increased Serum Hepcidin Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder" 대한정신약물학회 17 (17): 105-112, 2019

16 Campana WM, "Identification of a neurotrophic sequence in erythropoietin" 1 : 235-241, 1998

17 Shabani E, "High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria" 60 : 27-35, 2015

18 Casals-Pascual C, "High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria" 105 : 2634-2639, 2008

19 Conrad KP, "Expression of erythropoietin by the human placenta" 10 : 760-768, 1996

20 Malhotra S, "Erythropoietin(epoetin)as a protective factor for the brain" 6 : 301-306, 2004

21 Viviani B, "Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor" 93 : 412-421, 2005

22 Díez-Padrisa N, "Erythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican children" 6 : e24090-, 2011

23 Mahmoud AT, "Erythropoietin in the serum and cerebrospinal fluid of epileptic children" 19 : 185-192, 2005

24 Marti HH, "Erythropoietin gene expression in human, monkey and murine brain" 8 : 666-676, 1996

25 Brines ML, "Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury" 97 : 10526-10531, 2000

26 Nakamura T, "Elevated levels of erythropoietin in cerebrospinal fluid of depressed patients" 315 : 199-201, 1998

27 Mehler-Wex C, "Dopaminergic dysbalance in distinct basal ganglia neurocircuits : implications for the pathophysiology of Parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder" 10 : 167-179, 2006

28 American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" American Psychiatric Association 2013

29 Marti HH, "Detection of erythropoietin in human liquor : intrinsic erythropoietin production in the brain" 51 : 416-418, 1997

30 Schuster SJ, "Cellular sites of extrarenal and renal erythropoietin production in anaemic rats" 81 : 153-159, 1992

31 Barkley RA, "Attention-deficit hyperactivity disorder: a clinical workbook" Guilford Press 1991

32 Nigg JT, "An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences" 17 : 785-806, 2005

33 Kim JY, "An epidemiological study of attention-deficits hyperactivity disorder and learning disabilities in a rural area" 38 : 784-793, 1999

34 Masuda S, "A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes" 269 : 19488-19493, 1994